Previous 10 | Next 10 |
2024-04-21 22:55:15 ET Summary The stock market has been experiencing unusual volatility in the past few weeks. High-flying stocks like Nvidia, Eli Lilly, and GE Aerospace have experienced significant sell-offs. Nvidia's recent drop may be due to concerns about its relationshi...
2024-04-21 20:04:07 ET More on Eli Lilly, Novo Nordisk, etc. Read the full article on Seeking Alpha For further details see: 13 new obesity drugs could hit the market by 2029 amid surging demand
2024-04-21 14:42:04 ET More on the markets SPY: Higher For Longer Could Be Good News S&P 500: Positive Outlook, I'm Modifying My Hedge SPY: Resurgent Inflation, Soaring Yields, Geopolitical Turmoil - 1970s All Over Again? Wall Street's April pullback inte...
2024-04-20 12:03:00 ET Summary abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield of 11.3% and exposure to diverse subsectors of the healthcare industry. The fund outperforms its peers, abrdn World Healthcare Fund (THW) and BlackRock's Health Sciences Trust (BM...
2024-04-20 06:48:00 ET No risk, no reward. That's a fundamental part of investing. However, some stocks are less risky than others and still offer strong growth prospects. Three Motley Fool contributors think they've found relatively safe growth stocks you can buy and hold. Here's why t...
2024-04-19 17:10:14 ET More on ContraVir Seeking Alpha’s Quant Rating on ContraVir Historical earnings data for ContraVir Financial information for ContraVir Read the full article on Seeking Alpha For further details see: Hepion ends Phase ...
2024-04-18 10:00:06 ET Evan David Seigerman from BMO Capital issued a price target of $900.00 for LLY on 2024-04-18 08:39:00. The adjusted price target was set to $900.00. At the time of the announcement, LLY was trading at $748.4048. The overall price target consensus i...
2024-04-18 05:10:00 ET Think 10 years is not enough time to significantly grow your portfolio? Let's look at a couple of examples where investing $10,000 would have been enough to get your portfolio to more than six figures in a decade. Of course, these examples don't imply that t...
2024-04-17 18:51:53 ET For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side). Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical ...
2024-04-17 12:02:34 ET More on Eli Lilly Wall Street Lunch: Lilly In Limelight Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Eli Lilly obesity therapy succeeds in late-sta...
News, Short Squeeze, Breakout and More Instantly...
Eli Lilly and Company Company Name:
LLY Stock Symbol:
NYSE Market:
2024-05-19 06:15:00 ET Eli Lilly (NYSE: LLY) sells a broad portfolio of products, but two in particular have helped revenue growth explode in recent times. I'm talking about Lilly drugs that doctors prescribe for weight loss: Mounjaro and Zepbound. They're both based on the same mol...
2024-05-17 20:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...